Skip to main content
Fagron N.V. logo

Fagron N.V. — Investor Relations & Filings

Ticker · FAGR ISIN · BE0003874915 LEI · 549300TRKRUFK2RRG779 BR Manufacturing
Open in API
Filings indexed 1,987 across all filing types
Latest filing 2025-10-20 Transaction in Own Shar…
Country BE Belgium
Listing BR FAGR

About Fagron N.V.

https://fagron.com/

Fagron N.V. is a global company active in pharmaceutical compounding, focusing on the delivery of personalized medicine. The company optimizes and innovates compounding to widen the therapeutic options for prescribers worldwide. Fagron develops, markets, and distributes pharmaceutical raw materials, equipment, and specially formulated vehicles and bases, such as the Pentravan® transdermal base and the SyrSpend® range of oral suspending vehicles. Its primary customers are hospitals, pharmacies, and clinics. The company also operates in the field of genomics to further support personalized healthcare solutions.

Recent filings

Filing Released Lang Actions
Fagron’s share buy-back program: Weekly update
Transaction in Own Shares Classification · 100% confidence The document is a weekly update regarding Fagron's share buy-back program, detailing the number of shares purchased, the average price, and the total expenditure. This falls directly under the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2025-10-20 English
171025_Press release progress share buy back program Fagron - ENG.pdf
Transaction in Own Shares Classification · 100% confidence The document is a weekly update regarding Fagron's share buy-back program, detailing the number of shares purchased, the average price, and the total cost. This specifically describes the company buying back its own shares, which aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-10-17 English
171025_Press release progress share buy back program Fagron - NL.pdf
Transaction in Own Shares Classification · 100% confidence The document is a short announcement detailing the progress of a share buyback program (aandeleninkoopprogramma) by Fagron. It specifies the number of shares purchased, the average price, and the total amount spent, which directly aligns with the definition of a 'Transaction in Own Shares' (POS).
2025-10-17 Dutch
Fagron reports solid third quarter performance with 6.4% revenue growth and confirms full year outlook
Earnings Release Classification · 100% confidence The document is a press release announcing the company's Q3 2025 financial results. It provides key highlights, revenue growth figures, and management commentary. While it contains financial information, it is a summary announcement (press release) rather than a full interim report. According to the 'Menu vs Meal' rule, this is an Earnings Release (ER) as it provides the initial announcement of quarterly results with key highlights. Q3 2025
2025-10-09 Dutch
Fagron reports solid third quarter performance with 6.4% revenue growth and confirms full year outlook
Earnings Release Classification · 100% confidence The document is a quarterly trading update from Fagron for the period ending 30 September 2025. It provides key financial highlights, regional performance, outlook, and operational updates. While it contains financial data, it is an initial announcement of quarterly results (key highlights) rather than a full interim report or a 10-K. According to the filing definitions, this fits the 'Earnings Release' (ER) category, as it is the primary announcement of quarterly performance. Q3 2025
2025-10-09 English
Fagron rapporteert een solide resultaat in het derde kwartaal met een omzetgroei van 6,4% en bevestigt voor het hele jaar de verwachtingen
Earnings Release Classification · 100% confidence The document is a press release announcing the company's Q3 2025 financial results. It provides key highlights, revenue growth figures, and management commentary. While it contains financial information, it is a summary announcement (press release) rather than a full interim report. According to the 'Menu vs Meal' rule, this is an Earnings Release (ER) as it provides the initial announcement of quarterly results with key highlights. Q3 2025
2025-10-09 Dutch

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.